М. В. Шепелев

538 total citations
32 papers, 412 citations indexed

About

М. В. Шепелев is a scholar working on Molecular Biology, Genetics and Virology. According to data from OpenAlex, М. В. Шепелев has authored 32 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 9 papers in Genetics and 4 papers in Virology. Recurrent topics in М. В. Шепелев's work include CRISPR and Genetic Engineering (10 papers), RNA Interference and Gene Delivery (9 papers) and Virus-based gene therapy research (8 papers). М. В. Шепелев is often cited by papers focused on CRISPR and Genetic Engineering (10 papers), RNA Interference and Gene Delivery (9 papers) and Virus-based gene therapy research (8 papers). М. В. Шепелев collaborates with scholars based in Russia, United States and Italy. М. В. Шепелев's co-authors include Jonathan Chernoff, Clemens Hofmann, И. В. Коробко, Alexey V. Deykin, E. D. Sverdlov, E. P. Kopantzev, T. V. Vinogradova, Yegor Vassetzky, Dmitriy Mazurov and Anna Shmakova and has published in prestigious journals such as Journal of Cell Science, International Journal of Molecular Sciences and mBio.

In The Last Decade

М. В. Шепелев

30 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
М. В. Шепелев Russia	10	311	83	79	54	49	32	412
Valérie Bello France	13	270 0.9×	57 0.7×	100 1.3×	45 0.8×	44 0.9×	17	410
Moonsup Lee United States	12	413 1.3×	64 0.8×	86 1.1×	87 1.6×	67 1.4×	20	500
Pershang Farshi United States	10	320 1.0×	63 0.8×	55 0.7×	36 0.7×	59 1.2×	12	425
Nickolaos Nikiforos Giakoumakis Greece	10	367 1.2×	52 0.6×	94 1.2×	53 1.0×	37 0.8×	13	482
Nathalie Rocques France	9	489 1.6×	73 0.9×	129 1.6×	54 1.0×	71 1.4×	14	659
Naoki Mine Japan	10	416 1.3×	82 1.0×	84 1.1×	31 0.6×	99 2.0×	13	556
Øystein Røsok Norway	10	287 0.9×	57 0.7×	50 0.6×	75 1.4×	57 1.2×	14	381
Joanna Boros United Kingdom	11	498 1.6×	102 1.2×	60 0.8×	75 1.4×	39 0.8×	13	622
Karine Regazzoni United States	7	210 0.7×	79 1.0×	61 0.8×	62 1.1×	50 1.0×	8	373
Pooja Pungaliya United States	8	360 1.2×	142 1.7×	71 0.9×	36 0.7×	34 0.7×	8	456

Countries citing papers authored by М. В. Шепелев

Since Specialization

Citations

This map shows the geographic impact of М. В. Шепелев's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by М. В. Шепелев with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites М. В. Шепелев more than expected).

Fields of papers citing papers by М. В. Шепелев

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by М. В. Шепелев. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by М. В. Шепелев. The network helps show where М. В. Шепелев may publish in the future.

Co-authorship network of co-authors of М. В. Шепелев

This figure shows the co-authorship network connecting the top 25 collaborators of М. В. Шепелев. A scholar is included among the top collaborators of М. В. Шепелев based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with М. В. Шепелев. М. В. Шепелев is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Шепелев, М. В., et al.. (2024). Efficient Genome Editing Using ‘NanoMEDIC’ AsCas12a-VLPs Produced with Pol II-Transcribed crRNA. International Journal of Molecular Sciences. 25(23). 12768–12768. 1 indexed citations

Mazurov, Dmitriy, et al.. (2024). A New Chimeric Antibody against the HIV-1 Fusion Inhibitory Peptide MT-C34 with a High Affinity and Fc-Mediated Cellular Cytotoxicity. Biology. 13(9). 675–675. 2 indexed citations

Georgiev, Pavel, et al.. (2024). Generation of LEPR Knockout Rabbits with CRISPR/CAS9 System. Doklady Biological Sciences. 518(1). 248–255.

Шепелев, М. В., et al.. (2024). Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T Cells. Biomedicines. 12(1). 119–119. 10 indexed citations

Шепелев, М. В., et al.. (2023). Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: The Right Path towards Therapy. Biomedicines. 11(12). 3333–3333. 10 indexed citations

Шепелев, М. В., et al.. (2023). Efficient Editing of the CXCR4 Locus Using Cas9 Ribonucleoprotein Complexes Stabilized with Polyglutamic Acid. Doklady Biological Sciences. 513(S1). S28–S32. 1 indexed citations

Shmakova, Anna, et al.. (2022). Factors That Affect the Formation of Chromosomal Translocations in Cells. Cancers. 14(20). 5110–5110. 9 indexed citations

Шепелев, М. В., et al.. (2019). Миниген антитромбина III человека с оптимизированным паттерном сплайсинга. Молекулярная биология. 53(3). 411–420. 5 indexed citations

Шепелев, М. В., et al.. (2019). Xenobiotic Response Elements (XREs) from Human CYP1A1 Gene Enhance the hTERT Promoter Activity. Doklady Biochemistry and Biophysics. 485(1). 150–152. 4 indexed citations

10.

Коробко, И. В. & М. В. Шепелев. (2018). Мутации в эффекторном домене GTPазы RhoV нарушают взаимодействие с протеинкиназой Pak1. Молекулярная биология. 52(4). 692–698. 3 indexed citations

11.

Шепелев, М. В., et al.. (2017). A Novel Hybrid Promoter ARE-hTERT for Cancer Gene Therapy. Acta Naturae. 9(4). 66–74. 2 indexed citations

12.

Шепелев, М. В., et al.. (2017). A Novel Hybrid Promoter ARE-hTERT for Cancer Gene Therapy. Acta Naturae. 9(4). 66–73. 4 indexed citations

13.

Шепелев, М. В., E. P. Kopantzev, T. V. Vinogradova, E. D. Sverdlov, & И. В. Коробко. (2016). hTERT and BIRC5 gene promoters for cancer gene therapy: A comparative study. Oncology Letters. 12(2). 1204–1210. 14 indexed citations

14.

Шепелев, М. В., et al.. (2016). Выбор микроРНК для обеспечения опухолевой специфичности экспрессии трансгена при генной терапии рака. Молекулярная биология. 50(2). 327–335. 1 indexed citations

15.

Шепелев, М. В., et al.. (2016). Selection of microRNA for providing tumor specificity of transgene expression in cancer gene therapy. Molecular Biology. 50(2). 284–291. 2 indexed citations

16.

Шепелев, М. В., et al.. (2013). mTOR-dependent transcriptional repression of Pdcd4 tumor suppressor in lung cancer cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1839(1). 43–49. 12 indexed citations

17.

Шепелев, М. В. & И. В. Коробко. (2013). The RHOV gene is overexpressed in human non–small cell lung cancer. Cancer Genetics. 206(11). 393–397. 28 indexed citations

18.

Шепелев, М. В. & И. В. Коробко. (2012). Pak6 protein kinase is a novel effector of an atypical Rho family GTPase Chp/RhoV. Biochemistry (Moscow). 77(1). 26–32. 22 indexed citations

19.

Шепелев, М. В., et al.. (2011). Application of mRNA regulatory regions to improve tumor specificity of transgene expression. Cancer Gene Therapy. 18(9). 682–684. 6 indexed citations

20.

Шепелев, М. В., et al.. (2010). Pdcd4 tumor suppressor: Properties, functions, and possible applications in oncology. Molecular Genetics Microbiology and Virology. 25(2). 47–55. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact